摘要
前列腺特异性抗原 (PSA) 已被认为是区分前列腺癌的关键血清学标志物。 该调查显示了基于纳米材料的 PSA 电化学免疫传感器构建的最新进展。 本综述(2015 年至 2020 年)报告了基于使用不同类型纳米结构材料的 PSA 传感的最新进展。 最常用的纳米结构材料是金属、金属氧化物、碳基纳米材料,以及它们用于不同放大协议的混合结构。 在这篇综述中,用于前列腺特异性抗原传感的电化学免疫传感器分为三类,如夹心型@标记、无标记@非标记和基于适体的电化学免疫传感器。
关键词: 前列腺特异性抗原、癌症标志物、免疫传感器、免疫测定、纳米材料、纳米技术。
Current Medicinal Chemistry
Title:Electrochemical Immunosensors Based on Nanostructured Materials for Sensing of Prostate-Specific Antigen: A Review
Volume: 28 Issue: 20
关键词: 前列腺特异性抗原、癌症标志物、免疫传感器、免疫测定、纳米材料、纳米技术。
摘要: The prostate-specific antigen (PSA) has been considered a crucial serological marker for distinguishing prostate based cancer. This survey shows recent progress in the construction of nanomaterial-based electrochemical immunosensors for a PSA. This review (from 2015 to 2020) reports the latest progress in PSA sensing based on the employ of different types of nanostructured materials. The most popular used nanostructured materials are metal, metal oxide, carbon-based nanomaterials, and their hybrid architectures utilized for distinct amplification protocols. In this review, the electrochemical immunosensors for prostate-specific antigen sensing are classified into three categories such as sandwich type@labeled, label free@nonlabeled and aptamer-based electrochemical immunosensor.
Export Options
About this article
Cite this article as:
Electrochemical Immunosensors Based on Nanostructured Materials for Sensing of Prostate-Specific Antigen: A Review, Current Medicinal Chemistry 2021; 28 (20) . https://dx.doi.org/10.2174/0929867328666201124151821
DOI https://dx.doi.org/10.2174/0929867328666201124151821 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Panobinostat: The Small Molecule Metalloenzyme Inhibitor with Marvelous Anticancer Activity
Current Topics in Medicinal Chemistry Multicolor-FISH Approaches for the Characterization of Human Chromosomes in Clinical Genetics and Tumor Cytogenetics
Current Genomics Autophagy and Ubiquitination as Two Major Players in Colorectal Cancer: A Review on Recent Patents
Recent Patents on Anti-Cancer Drug Discovery Targeting Protein-Protein Interaction with Covalent Small-Molecule Inhibitors
Current Topics in Medicinal Chemistry Functional and Clinical Significance of the Integrin Alpha Chain CD49d Expression in Chronic Lymphocytic Leukemia
Current Cancer Drug Targets Amrubicin: A Synthetic Anthracyclin Analogue in the Treatment of Extensive Stage Small Cell Lung Cancer
Recent Patents on Anti-Cancer Drug Discovery Epithelial Cell Signaling in Helicobacter pylori Infection
Current Signal Transduction Therapy Multiple Functions of Rad9 for Preserving Genomic Integrity
Current Genomics Progress of Individualized Chemotherapy for Gastric Carcinoma Under the Guidance of Genetic Testing
Current Medicinal Chemistry The Applications of Biomarkers in Early Clinical Drug Development to Improve Decision-Making Processes
Current Clinical Pharmacology Molecular Targets for the Treatment of Multiple Myeloma
Current Cancer Drug Targets Compositions for Treatment of Cancer and Inflammation
Recent Patents on Anti-Cancer Drug Discovery Going 3D – Cell Culture Approaches for Stem Cell Research and Therapy
Current Tissue Engineering (Discontinued) Recent Patents on Cell Cycle Regulatory Proteins
Recent Patents on Biotechnology A Mini-Review on Nano Technology in the Tumour Targeting Strategies: Drug Delivery to Cancer Cells
Anti-Cancer Agents in Medicinal Chemistry Resveratrol: A New Potential Therapeutic Agent for Melanoma?
Current Medicinal Chemistry Synergies of Targeting Angiogenesis and Immune Checkpoints in Cancer: From Mechanism to Clinical Applications
Anti-Cancer Agents in Medicinal Chemistry ADAM8 in Allergy
Inflammation & Allergy - Drug Targets (Discontinued) Monoclonal Antibodies: A Prospective and Retrospective View
Current Medicinal Chemistry Meet Our Editorial Board Member:
Protein & Peptide Letters